Development
Vera Therapeutics, Inc.
VERA
$19.25
-$1.39-6.73%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.78% | 37.21% | 30.62% | 43.90% | 32.66% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.11% | -14.95% | 590.31% | 328.96% | 431.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 142.68% | 80.28% | -84.97% | 71.46% | -52.72% |
| Total Current Assets | 37.32% | 33.92% | 29.61% | 52.29% | 39.24% |
|
|
|||||
| Total Current Assets | 37.32% | 33.92% | 29.61% | 52.29% | 39.24% |
| Net Property, Plant & Equipment | -39.65% | -29.16% | -26.26% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.33% | 24.00% | 27.50% | 32.27% | 50.85% |
| Total Assets | 33.68% | 31.18% | 27.05% | 56.94% | 44.10% |
|
|
|||||
| Total Accounts Payable | 75.41% | 87.46% | -27.32% | 765.78% | 627.39% |
| Total Accrued Expenses | 57.63% | 41.96% | 53.69% | 84.95% | 129.40% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.36% | 4.49% | 4.50% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 54.65% | 55.30% | 17.83% | 232.90% | 293.86% |
|
|
|||||
| Total Current Liabilities | 54.65% | 55.30% | 17.83% | 232.90% | 293.86% |
| Long-Term Debt | 404.27% | 404.08% | 404.07% | 403.96% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -56.21% | -46.00% | -40.38% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.35% | 0.00% | -81.46% | -82.65% |
| Total Liabilities | 102.37% | 100.36% | 69.87% | 285.19% | 350.83% |
|
|
|||||
| Common Stock & APIC | 42.05% | 45.51% | 45.47% | 49.88% | 48.78% |
| Retained Earnings | -56.88% | -68.82% | -72.30% | -71.79% | -68.52% |
| Treasury Stock & Other | 73.12% | 6.58% | 66.67% | -- | -- |
| Total Common Equity | 17.02% | 15.65% | 17.32% | 10.51% | 23.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.02% | 15.65% | 17.32% | 10.51% | 23.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.02% | 15.65% | 17.32% | 10.51% | 23.68% |
|
|
|||||